SAILIFESai Life Sciences Limited
Healthcare · Diagnostics & Research · NSE · as of 2026-10-26 (delayed ~30 min in market hours)
Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It provides medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is based in Hyderabad, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on SAILIFE — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
The picture
- • Profit growth: 17.6% YoY
- • ROCE: 16.7%
- • Debt/Equity: 0.12
- • Price vs SMA200: above
- • Golden cross setup: SMA50 above SMA200
- • Trend strength (ADX): 29
Bull case
- • Profit growth: 17.6% YoY
- • ROCE: 16.7%
- • Debt/Equity: 0.12
- • Price vs SMA200: above
Bear case
- • Revenue growth: 3.9% YoY
- • Valuation vs sector: P/E 88.3 vs sector 45.7
- • MACD: bearish
- • Price vs EMA21: below
Key risks
- • Weak fundamentals — technical strength may not sustain
- • Revenue growth: 3.9% YoY
- • Valuation vs sector: P/E 88.3 vs sector 45.7
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹48.31). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.